EricKoMD

PubMed

• 13 citations
  Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neck.
  T.J. Carpenter, Benjamin H. Kann, Michael Buckstein, Eric C. Ko, Richard L. Bakst
  The Annals of Otology, Rhinology, and Laryngology. 2014-05-20
• 29 citations
  PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure.
  Eric C. Ko, Nelson N. Stone, Richard G. Stock
  International Journal of Radiation Oncology, Biology, Physics. 2012-06-01
• 166 citations
  The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer
  Eric C. Ko, David Raben, Silvia C. Formenti
  Clinical Cancer Research. 2018-12-01

Abstracts/Posters

• Adjusted risk stratification for Gleason score (GS) 8 prostate cancer patients treated with trimodality therapy
  Liu JT, Ko EC, Stone NN, Stock RG, ASTRO 2012, Boston, MA, USA
• The potential impact of medications on biochemical control following definitive management of prostate cancer
  Blacksburg SR, Ko EC, Stone NN, Stock RG, ASTRO 2012, Boston, MA, USA
• Association of genetic factors with PSA response in prostate cancer patients receiving definitive radiotherapy
  Ko E, Kerns SL, Stone NN, Stock RG, Ostrer H, Rosenstein BS, ASTRO 2012, Boston, MA, USA
• Quality of life with adjuvant radiotherapy following transoral robotic surgery (TORS) for head and neck cancer
  Carpenter TJ, Gupta V, Buckstein MH, Ko EC, Posner MR, Genden EM, ASTRO 2012, Boston, MA, USA
• PSA nadir of <0.5ng/ml following brachytherapy for early stage prostate adenocarcinoma predicts for freedom from PSA failure and distant metastasis
  Ko EC, Stone NN, Stock RG, ASTRO 2010, San Diego, CA, USA
• Early PSA failure time following brachytherapy predicts for decreased prostate-specific and overall survival
  Ko EC, Stone NN, Stock RG, ASTRO 2011, Miami Beach, FL, USA
• Join now to see all